Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ÃÊÀ½ÆÄ ÃøÁ¤ ³»ÀåÁö¹æ ÁöÇ¥¿Í ½ÉÇ÷°ü°è À§ÇèÀÎÀÚ¿ÍÀÇ °ü°è Association between ultrasonographic visceral fat indices and cardiovascular risk factors in type 2 diabetic patients

´ëÇѳ»°úÇÐȸÁö 2007³â 73±Ç 6È£ p.618 ~ 630
Á¤±ÍÈ«, ±è¼º±Õ, Á¤Áø¿í, Á¶µ¿Çõ, Á¤µ¿Áø, Á¤¹Î¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤±ÍÈ« ( Jeong Gwi-Hong ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç

±è¼º±Õ ( Kim Sung-Kyun ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤Áø¿í ( Chung Jin-Ook ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¶µ¿Çõ ( Cho Dong-Hyeok ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤µ¿Áø ( Chung Dong-Jin ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤¹Î¿µ ( Chung Min-Young ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç

Abstract

¸ñÀû : ºñ¸¸ ƯÈ÷ ³»Àåºñ¸¸Àº ÀϹÝÀΰú Á¦2Çü ´ç´¢º´¿¡¼­ ¸ðµÎ ½ÉÇ÷°ü°è ÁúȯÀÇ µ¶¸³ÀûÀÎ À§ÇèÀÎÀÚ·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸À» ÃøÁ¤ÇÏ´Â ¹æ¹ýÀº ´Ù¾çÇÏ¸ç ±× Áß¿¡¼­ ƯÈ÷ ³»ÀåÁö¹æÀÇ ¾çÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ¸·Î´Â Ç㸮µÑ·¹,ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ, ÀÌÁß¿¡³ÊÁö¹æ»ç¼±Èí¼ö¹ý ¹× ÃÊÀ½ÆÄÃøÁ¤¹ý µîÀÌ ÀÖ´Ù. º» ¿¬±¸¿¡¼­´Â Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ÃÊÀ½ÆÄ ÃøÁ¤ ³»ÀåÁö¹æ ÁöÇ¥¿Í ´Ù¸¥ ºñ¸¸ ÁöÇ¥¿ÍÀÇ »ó°ü°ü°è ¹× ´ë»çÁõÈıºÀ» ºñ·ÔÇÑ ½ÉÇ÷°ü°è ÁúȯÀÇ À§ÇèÀÎÀÚ¿ÍÀÇ °ü°è¸¦ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý : Àü³²´ëÇб³º´¿ø¿¡ Á¦2Çü ´ç´¢º´À¸·Î ³»¿øÇÑ È¯ÀÚ 191¸í(³²ÀÚ 101¸í, ¿©ÀÚ 90¸í)À» ´ë»óÀ¸·Î ÇÏ¿© ½ÉÇ÷°ü°è Áúȯ µîÀÇ °ú°Å·ÂÀ» ¹®ÁøÇÏ¿´°í, üÁú·®Áö¼ö, Ç㸮µÑ·¹ ¹× Ç÷¾ÐÀ» °èÃøÇÏ¿´´Ù. °øº¹Ç÷¾×°Ë»ç¸¦ ÅëÇÏ¿© ÁöÁú´ë »çÀÌ»ó°ú Àν¶¸° ÀúÇ×¼º Á¤µµ¸¦ ÃøÁ¤ÇÏ¿´°í, ´ç´¢º´¼º ¹Ì¼¼Ç÷°ü ÇÕº´Áõ°ú ´ëÇ÷°ü ÇÕº´Áõ ¿©ºÎ¸¦ °Ë»çÇÏ¿´´Ù. »ýüÀü±â ÀÓÇÇ´ø½º¹ýÀ» ÀÌ¿ëÇÑ Ã¼Áö¹æÃøÁ¤±â¸¦ ÀÌ¿ëÇÏ¿© üÁö¹æ·®, üÁö¹æ·ü ¹× º¹ºÎÁö¹æ·üÀ» ÃøÁ¤ÇÏ¿´´Ù. ÃÊÀ½Æİ˻縦 ÅëÇÏ¿© º¹ºÎ ¹é¼±À» µû¶ó ¹è²Å 1 cm »ó¹æ¿¡¼­ ³»Àå
Áö¹æ ¹× ÇÇÇÏÁö¹æµÎ²²¸¦ ÃøÁ¤ÇÏ¿´´Ù.

°á°ú : ÃÊÀ½ÆÄ ÃøÁ¤ ³»ÀåÁö¹æµÎ²²´Â üÁú·®Áö¼ö(r=0.444, p<0.001), Ç㸮µÑ·¹(r=0.466, p<0.001), üÁö¹æ·®(r=0.477,
p<0.001), º¹ºÎÁö¹æÀ²(r=0.274, p<0.001)°ú À¯ÀÇÇÑ »ó°ü°ü °è°¡ ÀÖ¾úÀ¸¸ç, HDL-ÄÝ·¹½ºÅ×·Ñ(r=-0.240, p<0.05)°ú °øº¹Àν¶¸°(r=0.266, p<0.05), °øº¹ Ç÷´ç/°øº¹ Àν¶¸° ºñ(r=-0.323, p<0.05), HOMA-IR (r=0.286, p<0.05)°ú À¯ÀÇÇÑ »ó°ü°ü°è¸¦ º¸¿´´Ù. ´ë»ó±º Áß¿¡¼­ ´ë»çÁõÈıºÀ» °¡Áø ȯÀÚµéÀÌ ¾ø´Â ȯÀڵ麸´Ù ÃÊÀ½ÆÄ ÃøÁ¤ ³»ÀåÁö¹æµÎ²²°¡ ´õ Áõ°¡ÇÏ¿´À¸¸ç, ³»ÀåÁö¹æµÎ²²¿¡ µû¶ó ´ë»ó ȯÀÚµéÀ» »ïºÐÀ§·Î ±¸ºÐÇÏ¿´À» ¶§ ¿¬·É, ¼ºº° ¹× üÁú·®Áö¼ö·Î º¸Á¤ÇÑ ÈÄ¿¡µµ ÇÏÀ§ »ïºÐÀ§±ºº¸´Ù »óÀ§ »ïºÐÀ§±º¿¡¼­ °íÇ÷¾Ð(OR=4.02, 95% CI; 1.08¢¦14.98), °íÁöÇ÷Áõ(OR=9.64, 95% CI; 1.08¢¦85.37), ´ë»çÁõÈıº(11.35, 95% CI; 1.34¢¦96.00)
ÀÇ À§Çèµµ°¡ Áõ°¡ÇÏ¿´´Ù.

°á·Ð : Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ÃÊÀ½Æĸ¦ ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ ³»ÀåÁö¹æÀº ³»Àåºñ¸¸ÀÇ À¯ÀÇÇÑ ÁöÇ¥°¡ µÉ ¼ö ÀÖÀ¸¸ç ´ë»çÁõÈıºÀ» ºñ·ÔÇÑ ½ÉÇ÷°ü°è ÁúȯÀÇ À§ÇèÀÎÀÚ Áß Çϳª·Î Á¦½ÃµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÈ´Ù.

Background : Visceral obesity is known as an independent risk factor of cardiovascular disease and metabolic syndrome. The objective of this study was to evaluate the association of ultrasonographic-determined visceral fat thickness and other parameters of obesity, metabolic syndrome, and risk factors of cardiovascular disease in type 2 diabetes.

Methods : A total of 191 type 2 diabetic patients (101 men and 90 women) participated in this study. Anthropometric, clinical, and laboratory data including the body mass index, waist circumference, blood pressure and lipid profiles were measured. Insulin resistance was calculated by using the homeostasis model assessment-insulin resistance (HOMA-IR). The visceral fat thickness was measured by abdominal ultrasonography at 1 cm above the umbilicus.

Results : The visceral fat thickness was positively correlated with the body mass index (p<0.001), waist circumference (p<0.001), fat mass (p<0.001), fat distribution (p<0.001), and HOMA-IR (p<0.05), whereas it was negatively correlated with theHDL-cholesterol level (p<0.05). The visceral fat thickness was better correlated with the presence of metabolic syndrome than with the subcutaneous fat thickness. The highest tertile of visceral fat thickness had a higher odds ratio for hypertension (OR=4.02, 95% CI 1.08¢¦14.98), dyslipidemia (OR=9.64, 95% CI 1.08¢¦85.37), and metabolic syndrome (OR=11.35, 95% CI 1.34¢¦96.00) than did those in the lowest tertile, after adjustment for age, sex, and body mass index.

Conclusions : The results of our study show that the measurement of abdominal visceral fat thickness using abdominal ultrasonography can be used as a reliable method to identify the risk for metabolic syndrome and cardiovascular disease in type 2 diabetic patients.

Å°¿öµå

Á¦2Çü ´ç´¢º´;ÃÊÀ½ÆÄ;³»ÀåÁö¹æ;½ÉÇ÷°ü°èÁúȯ
Type 2 diabetes mellitus;Ultrasonography;Visceral fat;Cardiovascular disease

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS